Trial Profile
Effectiveness of a Subcutaneously Administered Long-acting Insulin Added to Insulin Drip Therapy as Compared With Standard Insulin Drip Treatment.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2019
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Insulin; Insulin detemir
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 08 Jun 2012 Primary endpoint 'Glucose-level' has been met.
- 08 Jun 2012 Status changed from recruiting to completed.
- 08 Jun 2012 Results published in the Journal of Clinical Endocrinology and Metabolism.